SCHEMBL7690228

SCHEMBL7690228

N#Cc1ccc(Oc2ccccc2C(N)=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.68
PARP10 Q53GL7 2/20 0.59
PARP15 Q460N3 1/20 0.59
PARP2 Q9UGN5 1/20 0.59
MAPT P10636 3/20 0.49
KDM4E B2RXH2 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
SLC6A4 P31645 1/20 0.48
ICAM1 P05362 1/20 0.47
SELE P16581 1/20 0.47
VCAM1 P19320 1/20 0.47
CCNC P24863 1/20 0.47
CDK8 P49336 1/20 0.47
MEN1 O00255 2/20 0.46
LMNA P02545 2/20 0.46
KMT2A Q03164 2/20 0.46
POLB P06746 1/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL851138 0.86 CTNNB1 (0.51) CTNNB1PARP10PARP15PARP2MAPT
SCHEMBL8795188 0.84 CTNNB1 (0.49) CTNNB1PARP10PARP15PARP2MAPT
SCHEMBL7695689 0.84 CTNNB1 (0.62) CTNNB1KDM4ESMN1; SMN2IRAK4
SCHEMBL3786236 0.83 PARP15 (0.62) CTNNB1PARP10PARP15PARP2MAPT
SCHEMBL28876495 0.81 CTNNB1 (1.00) CTNNB1PARP10MAPTMEN1LMNA
SCHEMBL27680126 0.81 CTNNB1 (1.00) CTNNB1PARP10MAPTMEN1LMNA
SCHEMBL5724 0.81 CTNNB1 (1.00) CTNNB1PARP10MAPTMEN1LMNA
SCHEMBL27800575 0.80 CTNNB1 (0.77) CTNNB1PARP10MAPTMEN1LMNA
SCHEMBL1892492 0.80 CTNNB1 (0.77) CTNNB1PARP10MAPTKDM4EMEN1
Hydrochloric Acid SCHEMBL50731 0.80 CTNNB1 (0.96) CTNNB1PARP10MAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002016356-A2 QUINUCLIDINE-SUBSTITUTED ARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS) PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed
WO-2002016357-A2 QUINUCLIDINE-SUBSTITUTED ARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS) PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO disclosed